231 related articles for article (PubMed ID: 22587637)
1. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.
Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J
Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637
[TBL] [Abstract][Full Text] [Related]
2. Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.
Molenaar-de Backer MW; de Waal M; Sjerps MC; Koppelman MH
Transfusion; 2016 Feb; 56(2):440-8. PubMed ID: 26354230
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture.
Müller MM; Fraile MI; Hourfar MK; Peris LB; Sireis W; Rubin MG; López EM; Rodriguez GT; Seifried E; Saldanha J; Schmidt M
Vox Sang; 2013 Jan; 104(1):19-29. PubMed ID: 23252689
[TBL] [Abstract][Full Text] [Related]
4. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Hourfar MK; Schmidt M; Seifried E; Roth WK
Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
[TBL] [Abstract][Full Text] [Related]
6. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
Baylis SA; Buchheit KH
Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
9. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
Pichl L; Heitmann A; Herzog P; Oster J; Smets H; Schottstedt V
Transfusion; 2005 Jul; 45(7):1106-10. PubMed ID: 15987354
[TBL] [Abstract][Full Text] [Related]
10. A significantly lower potency observed for the 3rd WHO International Standard for Parvovirus B19V DNA with the cobas TaqScreen DPX test.
Pisani G; Cristiano K; Fabi S; Simeoni M; Marino F; Gaggioli A
Vox Sang; 2016 Aug; 111(2):115-9. PubMed ID: 27149002
[TBL] [Abstract][Full Text] [Related]
11. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
Rinckel LA; Buno BR; Gierman TM; Lee DC
Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
[TBL] [Abstract][Full Text] [Related]
12. Quantitative real-time detection of parvovirus B19 DNA in plasma.
Koppelman MH; Cuypers HT; Emrich T; Zaaijer HL
Transfusion; 2004 Jan; 44(1):97-103. PubMed ID: 14692974
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Parvovirus B19 and Hepatitis A virus in Portuguese blood donors.
Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Ferreira M; Araújo F
Transfus Apher Sci; 2005 Nov; 33(3):305-9. PubMed ID: 16203176
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the virus-elimination efficacy of nanofiltration (Viresolve NFP) for the parvovirus B19 and hepatitis A virus].
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS; Kim IS
Korean J Lab Med; 2010 Feb; 30(1):45-50. PubMed ID: 20197722
[TBL] [Abstract][Full Text] [Related]
15. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives.
Jia J; Ma Y; Zhao X; Guo Y; Huangfu C; Fang C; Fan R; Lv M; Yin H; Zhang J
Virol J; 2015 Oct; 12():162. PubMed ID: 26445095
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China.
Han T; Li C; Zhang Y; Wang Y; Wu B; Ke L; Liu G; Li L; Liu Y; Liu Z
Transfus Med; 2015 Dec; 25(6):406-10. PubMed ID: 26564017
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
19. Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay.
Koppelman MH; van Swieten P; Cuijpers HT
Transfusion; 2011 Jun; 51(6):1346-54. PubMed ID: 21175647
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
Modrof J; Berting A; Tille B; Klotz A; Forstner C; Rieger S; Aberham C; Gessner M; Kreil TR
Transfusion; 2008 Jan; 48(1):178-86. PubMed ID: 17900278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
